Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
I-Mab ADR
(NQ:
IMAB
)
1.215
+0.015 (+1.25%)
Streaming Delayed Price
Updated: 3:59 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
122,695
Open
1.210
Bid (Size)
1.200 (139)
Ask (Size)
1.250 (7)
Prev. Close
1.200
Today's Range
1.190 - 1.250
52wk Range
0.9900 - 2.536
Shares Outstanding
185,613,662
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Week In Review: Structure Reports Efficacy Of Obesity Drug; Raises $476 Million
June 08, 2024
Structure Therapeutics announced positive clinical results for its obesity drug, and then raised $476 million via an offering of its ADSs. Meanwhile, Alphamab Oncology announced a deal with ArriVent...
Via
Talk Markets
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
June 05, 2024
Via
Benzinga
Performance
YTD
-46.00%
-46.00%
1 Month
-13.83%
-13.83%
3 Month
-30.57%
-30.57%
6 Month
-25.91%
-25.91%
1 Year
-35.71%
-35.71%
More News
Read More
12 Health Care Stocks Moving In Tuesday's Intraday Session
June 04, 2024
Via
Benzinga
(IMAB) - Analyzing I-MAB's Short Interest
May 07, 2024
Via
Benzinga
NVIDIA To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Monday
March 18, 2024
Via
Benzinga
Looking Into I-MAB's Recent Short Interest
February 07, 2024
Via
Benzinga
Expert Ratings for I-MAB
September 25, 2023
Via
Benzinga
Where I-MAB Stands With Analysts
September 05, 2023
Via
Benzinga
Week In Review: I-Mab Morphs Into US-Only Company; Sells China Assets For $80 Million
February 11, 2024
Via
Talk Markets
12 Health Care Stocks Moving In Friday's After-Market Session
December 15, 2023
Via
Benzinga
Week In Review: Two China Biopharmas Announce Billion Dollar Deals
October 14, 2023
Via
Talk Markets
Week In Review: Adlai Nortye Stages $97.5 Million US IPO On Nasdaq
September 30, 2023
Via
Talk Markets
Topics
Initial Public Offering
Exposures
Securities Market
Analyst Ratings for I-MAB
August 18, 2023
Via
Benzinga
5 Analysts Have This to Say About I-MAB
June 05, 2023
Via
Benzinga
I-Mab Reveals Promising Results in Phase 1b/2 Study for Advanced Non-Small Cell Lung Cancer Treatment
May 26, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
September 28, 2023
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
September 28, 2023
Via
InvestorPlace
Week In Review: GenFleet Out-Licenses Three Candidates To Verastem In $625 Million Deal
September 02, 2023
Via
Talk Markets
7 F-Rated Biotech Stocks You Shouldn’t Touch With a 10-Foot Pole
August 25, 2023
Via
InvestorPlace
Why Is TRACON Pharma (TCON) Stock Down 51% Today?
April 25, 2023
Via
InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
April 25, 2023
Via
InvestorPlace
Last Day Of Q1
March 31, 2023
Via
Benzinga
ImmuneOnco Banks On Cutting-edge Cancer Drugs To Attract IPO Cash
March 31, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Monday
March 27, 2023
Via
Benzinga
Why Omeros Are Trading Higher By 32%? Here Are Other Stocks Moving In Monday's Mid-Day Session
February 06, 2023
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.